TGFB1 and idiopathic pulmonary fibrosis: Previous studies have shown that delivering siTGF-β1 via liposomes can effectively inhibit the expression of TGF-β1 in pulmonary epithelial cells and fibroblasts, thereby alleviating the symptoms of idiopathic pulmonary fibrosis (IPF) [25].